Moderna, Inc. Share Price

Moderna, Inc. Share Price

NASDAQ: MRNA | Large Cap
$221.05
+$7.02 (3.28%) Last updated on 29 Oct, 2026 | 20:40 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Moderna, Inc. Stock Performance

Open
$217.61
Prev. Close
$214.03
Circuit Range
N/A
Day Range
$215.35 - $225.00
Year Range
$22.28 - $254.43
Volume
1,46,419
Average Traded
$220.54

Moderna, Inc. Share Price Today

As of 29 October 2026, Moderna, Inc.'s share price is $221.05. The stock opened at $217.61, compared to its previous close of $214.03. During today's trading session, Moderna, Inc.'s share price traded between $215.35 and $225.00, with an average price of $220.18. Over the past 52 weeks, the stock has recorded a high of $254.43 and a low of $22.28. In terms of performance, Moderna, Inc.'s share price has risen by 381.59% over the last six months and is up 713.88% on a year-on-year basis.

Moderna, Inc. Share Price Chart

Line chart of the Moderna, Inc. price trend over the selected period. The price rose overall, ranging from 216.66 to 224.69, ending at 221.05.
$215.35$225.00
L
Show Current Price
H

Moderna, Inc. Stock Fundamentals & Key Indicators

Market Cap
$85.99B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-7.89
Revenue (TTM)
$1.94B
Return On Equity (TTM)
-46.61%
Profit Margin
-145.36%
Debt to Equity
0.09
Quarterly Earnings Growth YoY
-291.00%

Moderna, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$1016.00$678.00$389.00$145.00
Net Profit-$200.00-$826.00-$1343.00-$782.00
Net Profit Margin-19.69%-121.83%-345.24%-539.31%
Income ChangeN/A-313.00%-62.59%41.77%

Moderna, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$19.26$6.85$3.24$1.94
Net Profit$8.36-$4.71-$3.56-$2.82
Net Profit Margin43.41%-68.76%-109.88%-145.36%
Income ChangeN/A-156.34%24.42%20.79%

About Moderna, Inc.

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 25 mRNA development candidates in clinical studies as of March 2026. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Moderna, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$186.61
$220.75
+14.60%
Sep 2026
$139.40
$192.63
+34.98%
Aug 2026
$54.92
$142.71
+160.23%
Jul 2026
$70.28
$54.84
-21.66%
Jun 2026
$46.80
$70.00
+48.37%
May 2026
$46.43
$47.18
+2.79%
Apr 2026
$51.74
$45.90
-9.68%
Mar 2026
$52.42
$50.82
-5.20%
Feb 2026
$43.19
$53.61
+21.56%
Jan 2026
$29.87
$44.10
+49.54%
Dec 2025
$25.00
$29.49
+13.55%
Nov 2025
$26.48
$25.97
-4.38%

MRNA Share Price FAQs